Amlitelimab
Promising Phase IIb Results in Atopic Dermatitis: amlitelimab as a Groundbreaking Treatment
SG Tylor
Source – Sanofi On June 27, 2023, Sanofi announced positive Phase IIb Results. Amlitelimab shows promise as a first-in-class investigational ...
